Cowen and Company’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-106,400
Closed -$414K 652
2022
Q4
$414K Buy
+106,400
New +$1.09M 0.04% 138
2022
Q3
Sell
-126,000
Closed -$173K 731
2022
Q2
$173K Buy
+126,000
New +$1.87M 0.02% 215
2021
Q4
Sell
-59,000
Closed -$25K 725
2021
Q3
$25K Buy
+59,000
New +$2.04M ﹤0.01% 465
2021
Q2
Sell
-75,000
Closed -$15K 652
2021
Q1
$15K Buy
+75,000
New +$3.46M ﹤0.01% 469

Other funds holding MSOS

Cowen and Company's MSOS Position: Q4 2023 in Review

Cowen and Company sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2023, closing a stake of 6,139,280 shares — an estimated $48.7M sold.

Cowen and Company first reported a position in MSOS in Q2 2021 and held it in 9 quarters. The position peaked at $48.7M in Q3 2023. 171 funds tracked by Wall St. Rank hold MSOS as of Q4 2023.

  • Cowen and Company reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2023 after selling out during the quarter.
  • Cowen and Company sold 6,139,280 AdvisorShares Pure US Cannabis ETF shares in Q4 2023, an estimated $48.7M.
  • Cowen and Company first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and held it in 9 quarters.
  • Cowen and Company's AdvisorShares Pure US Cannabis ETF position peaked at $48.7M in Q3 2023.
  • 171 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.